BACKGROUND: Surgical resection is the standard of care for patients with resectable non-small cell lung cancer or selected patients with pulmonary metastases. However, for high-risk patients radiofrequency ablation (RFA) may offer an alternative option. The objective of this study was to evaluate computed tomography-guided RFA for high-risk patients and report our initial experience in 100 consecutive patients by a thoracic surgical service. METHODS: Medically inoperable patients were offered RFA. Thoracic surgeons evaluated and performed RFA under computed tomography guidance. Patients were followed in the thoracic surgery clinic. The primary end point evaluated was overall survival. RESULTS: One hundred patients underwent image-guided RFA for lung neoplasm (40 men, 60 women; median age, 73.5 years; range, 26 to 95 years). Forty-six patients (46%) with primary lung neoplasm, 25 patients (25%) with recurrent cancer, and 29 patients (29%) with pulmonary metastases underwent RFA. The mean follow-up for alive patients was 17 months. The median overall survival for the entire group of patients was 23 months. The probabilities of 2-year overall survival for the entire group, primary lung cancer patients, recurrent cancer patients, and metastatic cancer patients were 49% (95% confidence interval, 37 to 60), 50% (95% confidence interval, 33 to 65), 55% (95% confidence interval, 25 to 77), and 41% (95% confidence interval, 19 to 62), respectively. CONCLUSIONS: Our experience indicates that image-guided RFA done by the thoracic surgeons is feasible and safe in high-risk patients with lung neoplasm with reasonable results in patients who are not fit for surgery. Thoracic surgeons can perform RFA safely, and should continue to investigate this new image-guided modality that may offer an alternative option in medically inoperable patients.
BACKGROUND: Surgical resection is the standard of care for patients with resectable non-small cell lung cancer or selected patients with pulmonary metastases. However, for high-risk patients radiofrequency ablation (RFA) may offer an alternative option. The objective of this study was to evaluate computed tomography-guided RFA for high-risk patients and report our initial experience in 100 consecutive patients by a thoracic surgical service. METHODS: Medically inoperable patients were offered RFA. Thoracic surgeons evaluated and performed RFA under computed tomography guidance. Patients were followed in the thoracic surgery clinic. The primary end point evaluated was overall survival. RESULTS: One hundred patients underwent image-guided RFA for lung neoplasm (40 men, 60 women; median age, 73.5 years; range, 26 to 95 years). Forty-six patients (46%) with primary lung neoplasm, 25 patients (25%) with recurrent cancer, and 29 patients (29%) with pulmonary metastases underwent RFA. The mean follow-up for alive patients was 17 months. The median overall survival for the entire group of patients was 23 months. The probabilities of 2-year overall survival for the entire group, primary lung cancerpatients, recurrent cancerpatients, and metastatic cancerpatients were 49% (95% confidence interval, 37 to 60), 50% (95% confidence interval, 33 to 65), 55% (95% confidence interval, 25 to 77), and 41% (95% confidence interval, 19 to 62), respectively. CONCLUSIONS: Our experience indicates that image-guided RFA done by the thoracic surgeons is feasible and safe in high-risk patients with lung neoplasm with reasonable results in patients who are not fit for surgery. Thoracic surgeons can perform RFA safely, and should continue to investigate this new image-guided modality that may offer an alternative option in medically inoperable patients.
Authors: Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith Journal: Circulation Date: 2002-03-12 Impact factor: 29.690
Authors: Richard I Whyte; Richard Crownover; Martin J Murphy; David P Martin; Thomas W Rice; Malcolm M DeCamp; Raymond Rodebaugh; Martin S Weinhous; Quynh-Thu Le Journal: Ann Thorac Surg Date: 2003-04 Impact factor: 4.330
Authors: Jeong Min Lee; Ji Hyun Youk; Young Kon Kim; Young Min Han; Gyung Ho Chung; Sang Yong Lee; Chong Soo Kim Journal: Eur Radiol Date: 2003-04-18 Impact factor: 5.315
Authors: Cliff K Choong; Bryan F Meyers; Richard J Battafarano; Tracey J Guthrie; Gail E Davis; G Alexander Patterson; Joel D Cooper Journal: J Thorac Cardiovasc Surg Date: 2004-05 Impact factor: 5.209
Authors: O Birim; A P W M Maat; A P Kappetein; J P van Meerbeeck; R A M Damhuis; A J J C Bogers Journal: Eur J Cardiothorac Surg Date: 2003-01 Impact factor: 4.191
Authors: Luis J Herrera; Hiran C Fernando; Yaron Perry; William E Gooding; Percival O Buenaventura; Neil A Christie; James D Luketich Journal: J Thorac Cardiovasc Surg Date: 2003-04 Impact factor: 5.209
Authors: G Carrafiello; M Mangini; F Fontana; A Di Massa; A M Ierardi; E Cotta; F Piacentino; L Nocchi Cardim; C Pellegrino; C Fugazzola Journal: Radiol Med Date: 2011-10-21 Impact factor: 3.469